Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

Chang JY, Balter PA, Dong L, Yang Q, Liao Z, Jeter M, Bucci MK, McAleer MF, Mehran RJ, Roth JA, Komaki R.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):967-71. doi: 10.1016/j.ijrobp.2008.08.001.

PMID:
18954709
[PubMed - indexed for MEDLINE]
2.

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications.

Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R.

Radiother Oncol. 2010 Jan;94(1):1-11. doi: 10.1016/j.radonc.2009.12.008. Epub 2010 Jan 13. Review.

PMID:
20074823
[PubMed - indexed for MEDLINE]
3.

Stereotactic body radiation therapy for stage I non-small cell lung cancer.

Chang JY, Roth JA.

Thorac Surg Clin. 2007 May;17(2):251-9. Review.

PMID:
17626403
[PubMed - indexed for MEDLINE]
4.

Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review.

van Baardwijk A, Tomé WA, van Elmpt W, Bentzen SM, Reymen B, Wanders R, Houben R, Ollers M, Lambin P, De Ruysscher D.

Radiother Oncol. 2012 Nov;105(2):145-9. doi: 10.1016/j.radonc.2012.09.008. Epub 2012 Oct 12. Review.

PMID:
23068707
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk